Aeglea BioTherapeutics, Inc.
We are a clinical-stage biotechnology company that designs and develops innovative human enzyme therapeutics for patients with rare genetic diseases and cancer.
Evercore ISI, BMO Capital Markets, Jones Trading
To view the prospectus for Aeglea BioTherapeutics, Inc., or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277